Company / R&D per Share
GoodRx Holdings, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.29
FY2025
5-year range
$0.29 / $0.54
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#230 of 259
Information Technology
What the data says
GoodRx Holdings, Inc.'s r&d per share of $0.29 is lower than 89% of companies in the Information Technology sector (FY2025). R&D per Share has declined for 4 consecutive years, from $0.54 in FY2021 to $0.29 in FY2025.
Based on SEC 10-K filings.
0.29 in FY2025 with a 5-year CAGR of -10.8%.
Declined from $0.33 to $0.29 over the past 2 years.
Information Technology sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -17.3%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Information TechnologyTop 89% of 259This company $0.29 Sector average $6395.95
▼
-100.0% below sector average
Key checks
Key Insights
- GoodRx Holdings, Inc.'s r&d per share has declined for 4 consecutive years.
- In FY2025, r&d per share decreased 1.6% year-over-year.
- Ranks #230 out of 259 companies in the Information Technology sector.
- Peak r&d per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | -1.6% |
| FY2024 | $0.30 | -9.5% |
| FY2023 | $0.33 | -36.4% |
| FY2022 | $0.52 | -4.3% |
| FY2021 | $0.54 | +4.2% |
| FY2020 | $0.52 | +312.2% |
| FY2019 | $0.13 | -65.8% |
| FY2018 | $0.37 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026